Actively Recruiting
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Led by University of California, San Diego · Updated on 2026-04-09
26
Participants Needed
1
Research Sites
11 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
L
Livivos, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a new technology to evaluate the liver (LiverScope®). We will compare LiverScope® to other methods to evaluate the liver, including advanced conventional liver MR exams. MR exams are common exams used to monitor MASLD (also known as NAFLD). Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this second phase of the study, we took what we learned in the first phase to optimize the LiverScope® device and are now testing to see how LiverScope® measurements compare to MR after these optimizations. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires
CONDITIONS
Official Title
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Known or clinically suspected MASLD
- Body mass index (BMI) greater than 27 kg/m² and less than 45 kg/m² at the time of referral
- Ability to lie on LiverScope4 device table for about 60 minutes
- Ability to hold breath repeatedly for about 20 seconds during MR and LiverScope4 exams
- Willing and able to undergo all study procedures
You will not qualify if you...
- UCSD study personnel or Livivos study personnel
- Contraindications to MR
- Pregnant, thinks may be pregnant, or trying to become pregnant
- Known chronic liver disease other than MASLD
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Diego
La Jolla, California, United States, 92037
Actively Recruiting
Research Team
Y
Yesenia Covarrubias
CONTACT
G
Gage Tanzman
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here